To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer

Detalles Bibliográficos
Autor principal: Horinouchi, Hidehito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214908/
https://www.ncbi.nlm.nih.gov/pubmed/32411777
http://dx.doi.org/10.21037/atm.2020.01.66
_version_ 1783532072998010880
author Horinouchi, Hidehito
author_facet Horinouchi, Hidehito
author_sort Horinouchi, Hidehito
collection PubMed
description
format Online
Article
Text
id pubmed-7214908
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-72149082020-05-14 To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer Horinouchi, Hidehito Ann Transl Med Editorial Commentary AME Publishing Company 2020-04 /pmc/articles/PMC7214908/ /pubmed/32411777 http://dx.doi.org/10.21037/atm.2020.01.66 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Horinouchi, Hidehito
To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
title To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
title_full To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
title_fullStr To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
title_full_unstemmed To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
title_short To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer
title_sort to combine or not to combine: anti-vascular endothelial growth factor therapies in egfr mutation positive non-small cell lung cancer
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214908/
https://www.ncbi.nlm.nih.gov/pubmed/32411777
http://dx.doi.org/10.21037/atm.2020.01.66
work_keys_str_mv AT horinouchihidehito tocombineornottocombineantivascularendothelialgrowthfactortherapiesinegfrmutationpositivenonsmallcelllungcancer

Ejemplares similares